Andembry Injection, Solution
Product Images NDC 63833-925

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Andembry (NDC 63833-925). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Csl, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure A (Garadacimab 01)

Figure A (Garadacimab 01)
This text appears to be instructions for using an autoinjector device. It explains how to handle the autoinjector before and after use, including details about the expiration date, the components like the plunger stopper and needle shield, as well as the process of injection. It also emphasizes caution about touching the needle inside the autoinjector. The instructions outline how the autoinjector functions after use, such as the locking mechanism for the viewing window and the plunger filing.*
FDA Label Image

Figure B (Garadacimab 02)

Figure B (Garadacimab 02)
This text describes a set of items commonly used for medical purposes, including alcohol pads, cotton balls, and a sharps container. It also mentions a single-dose autoinjector. Some items are noted as included, while others are required but not included in the set.*
FDA Label Image

Figure C (Garadacimab 03)

Figure C (Garadacimab 03)
FDA Label Image

Figure D (Garadacimab 04)

Figure D (Garadacimab 04)
FDA Label Image

Figure E (Garadacimab 05)

Figure E (Garadacimab 05)
FDA Label Image

Figure F (Garadacimab 06)

Figure F (Garadacimab 06)
FDA Label Image

Figure G (Garadacimab 07)

Figure G (Garadacimab 07)
FDA Label Image

Figure H (Garadacimab 08)

Figure H (Garadacimab 08)
FDA Label Image

Figure I (Garadacimab 09)

Figure I (Garadacimab 09)
This is a product description for a gray needle shield and clear autoinjector cap. The gray needle shield should not be touched, and the clear autoinjector cap is likely meant to be removed before use.*
FDA Label Image

Figure J (Garadacimab 10)

Figure J (Garadacimab 10)
FDA Label Image

Image (Garadacimab 11)

Image (Garadacimab 11)
FDA Label Image

Figure K (Garadacimab 12)

Figure K (Garadacimab 12)
FDA Label Image

Figure L (Garadacimab 13)

Figure L (Garadacimab 13)
FDA Label Image

Figure M (Garadacimab 14)

Figure M (Garadacimab 14)
FDA Label Image

Principal Display Panel (200 mg Pen Label)

Principal Display Panel (200 mg Pen Label)
This is a description of a medication called Fanembry® (garadacimab-oxi) in injection form, with a strength of 200 mg/1.2mL. It is intended for subcutaneous use and comes in a single-dose prefilled syringe. The medication is manufactured by CSL Behring LLC in King of Prussia, PA, with a lot number and expiration date provided. It is important to read the instructions before use.*
FDA Label Image

Principal Display Panel (200 mg Pen Carton)

Principal Display Panel (200 mg Pen Carton)
Contents: Each single-dose prefilled autoinjector contains 200 mg of garadacimab-gxi in 1.2 mL. The formulation includes arginine monohydrochloride, histidine, polysorbate 80, proline, and water for injection. It does not contain any preservatives. The recommended dosage can be found in the prescribing information. Storage guidelines indicate refrigerating the autoinjector between 36°F to 46°F and avoiding freezing or shaking. The product must be kept in its original carton to protect it from light. Used products and disposable supplies should be discarded, and it should be kept out of reach of children. It is advised not to use the solution if it appears cloudy or contains particulates. To enroll in the confidential industry-wide Patient Notification System, a specific number is provided. The product is manufactured for distribution by L. Behring LLC, with details provided for contact and location. The text also includes information on the product's composition and indications for use.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.